Advancements in Technology Boost Monitoring of Critical Quality Attributes in mAb Development
February 9, 2025 - 05:33
The monoclonal antibody (mAb) market is experiencing significant growth, valued at over $330 billion and projected to more than double by 2030. This surge in demand is driving innovation within the industry, particularly in the area of technology that aids in monitoring critical quality attributes (CQAs) during mAb development.
As developers strive to enhance the safety and efficacy of these therapeutic proteins, new technological tools are emerging that streamline the monitoring process. These advancements enable more precise measurements and real-time data analysis, allowing for better control over the production process. Consequently, manufacturers can ensure that their products meet stringent regulatory standards while also improving overall yield and reducing costs.
The integration of cutting-edge technologies, such as artificial intelligence and advanced analytics, is transforming how mAb developers operate. With these tools, the industry is poised to enhance product quality and accelerate the development timeline, ultimately benefiting patients who rely on these vital therapies.
MORE NEWS
July 10, 2026 - 17:09
Economic uncertainty is forcing cities to rethink technology investments, AI and resilienceA new annual report from the National League of Cities reveals a significant shift in how local governments are prioritizing technology. As economic headwinds persist, city leaders are no longer...
July 9, 2026 - 19:42
The Next AI Race Will Be Decided by Judgment, Not IntelligenceAs artificial intelligence agents begin to reshape customer service, sales, and support, a growing number of industry leaders are rethinking what will separate winners from losers. The conventional...
July 9, 2026 - 01:55
$9.3B Japan Factory Expansion Assert Micron Technology Inc. (MU) as a Top AI Stock on Wall Street RadarMicron Technology Inc. is drawing attention on Wall Street as a key player in the artificial intelligence space. The company recently broke ground on a major expansion of a factory located in...
July 8, 2026 - 10:45
Nocera Expands Diversified Technology Strategy With Binding Agreement to Acquire an Equity Interest in INERGX, an Integrated Energy Storage and Power Platform for AI, Defense and Mission-Critical DemandNocera, Inc. has signed a binding agreement to purchase an equity interest in INERGX, an energy storage and power platform focused on mission-critical applications. The deal positions the company...